Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

William Blair Downgrades Akouos to Market Perform

William Blair analyst Sami Corwin downgrades Akouos (NASDAQ:AKUS) from Outperform to Market Perform.

byBenzinga Newsdesk

October 19, 2022

1 minute read

William Blair analyst Sami Corwin downgrades Akouos (NASDAQ:AKUS) from Outperform to Market Perform.

Barclays Maintains Equal-Weight on UiPath, Lowers Price Target to $70

By vishwanath@benzinga.com

Today, 4:48 AM

Barclays analyst Raimo Lenschow maintains UiPath (NYSE:PATH) with a Equal-Weight and lowers the price target from $73 to $70.

PATH

Analyst Ratings

Expert Ratings for Affirm Holdings

By Benzinga Insights

Today, 4:48 AM

Analysts have provided the following ratings for Affirm Holdings (NASDAQ:AFRM) within the last quarter: Bullish Somewhat Bullish Indifferent…

AFRM

Will $286M Tryke Deal Improve Curaleaf’s Operating Margin? Analyst’s Thoughts Ahead Earnings

By Nina Zdinjak

Today, 4:48 AM

Cannabis giant Curaleaf Holdings, Inc. (OTCQX: CURLF) announced Monday that it has entered into a definitive agreement to acquire Tryke Companies, which is doing business as Reef Dispensaries.

CURLF

Wells Fargo Maintains Overweight on Rambus, Raises Price Target to $50

By Benzinga Newsdesk

Today, 4:48 AM

Wells Fargo analyst Gary Mobley maintains Rambus (NASDAQ:RMBS) with a Overweight and raises the price target from $42 to $50.

RMBS

William Blair Downgrades Akouos to Market Perform

Related Posts

Barclays Maintains Equal-Weight on UiPath, Lowers Price Target to $70

Expert Ratings for Affirm Holdings

Will $286M Tryke Deal Improve Curaleaf’s Operating Margin? Analyst’s Thoughts Ahead Earnings

Wells Fargo Maintains Overweight on Rambus, Raises Price Target to $50